A Spanish startup has become one of only four companies authorised by Spain’s medicines regulator to cultivate medical cannabis, positioning
Ever since the Christian Democratic Union (CDU) became the largest party in Germany’s ruling coalition government in February 2025, the
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians and policymakers from across the global cannabis
Last week (April 27), the deadline for Greek industry stakeholders to have their say on a controversial new hemp ban
In April 2025, the Italian government used emergency constitutional powers to bypass parliament and reclassify non-intoxicating hemp as a narcotic,
The M&A scramble for Europe has continued at a fearsome pace over the last few weeks. Organigram has closed its
This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times,
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018.
More than 70 international speakers and over 1000 delegates set to convene on London next month for policy debates, high-level
As the European medical cannabis market has developed, expanded and matured over the last half-decade, Portugal has played a critical
Last year, as other European cannabis markets looked to be retreating from their ambitious progress in 2024, Switzerland accelerated its
Germany’s Bundesrat voted on November 21 to support key restrictions on medical cannabis prescribing and distribution, while rejecting proposals to
Why Reading Research Matters The volume of cannabis research has never been higher, but not all studies are created equal.
As New Yorkers prepare to head to the polls to vote for their new Mayor tomorrow (Tuesday, November 04), the
Next Thursday, 6 November 2025, Business of Cannabis: New York returns to The Wythe Hotel, Williamsburg, uniting more than 300
The European medical cannabis industry is continuing to mature, seeing companies focused on science-based research push the boundaries of our
The United States is intensifying its controversial overseas ‘war on drugs’ even as a prolonged government shutdown paralyses domestic policy,
Industry leaders, regulators and investors meet at Business of Cannabis New York to discuss funding, regulation and sustainable market growth.
We won’t spam you
